在T细胞急性淋巴细胞白血病中,NKX2-1作为RUNX1的辅因子调节细胞生存,成熟和DNA损伤反应
Linde Van Aerschot1, Sofie Demeyer2, Kalina Timcheva1
1Laboratory for Disease Mechanisms in Cancer, Department of Oncology, KU Leuven, Belgium; Laboratory for Disease Mechanisms in Cancer, Leuven Cancer Institute (LKI), Leuven.
Haematologica
|January 8, 2026
概括
转录因子NKX2-1通过保护DNA受损而提高T细胞急性淋巴细胞白血病 (T-ALL) 细胞存活率. RUNX1充当辅助因子,表明在T-ALL病变发生过程中具有合作作用.
科学领域:
- * 血液瘤学
- * 分子生物学 * 分子生物学
- * 癌症遗传学 癌症遗传学
背景情况:
- *T细胞急性淋巴细胞白血病 (T-ALL) 涉及异常的转录因子表达.
- *NKX2-1在5%的T-ALL病例中过度表达,与皮质免疫表型和血清/糖氨酸代谢有关.
- *NKX2-1在T-ALL病变发生中的确切作用需要进一步阐明.
研究的目的:
- * 调查NKX2-1在T-ALL病变发生中的功能.
- * 描述NKX2-1对T-ALL细胞表型,细胞周期和DNA损伤反应的影响.
- * 确定参与T-ALL中NKX2-1介导的转录调节的辅助因子.
主要方法:
- * CRISPR-Cas9介导的NKX2-1在T-ALL细胞系RPMI-8402.2中的淘汰作用.
- * 在患者衍生T-ALL样本中验证发现.
- * 免疫类型,细胞周期进展,细胞亡,DNA损伤修复基因表达和蛋白质-DNA相互作用的分析.
主要成果:
- *NKX2-1淘汰导致免疫类型不成熟,细胞循环进展增加,与CDK6抑制相关.
- *NKX2-1对细胞亡和DNA损伤进行了保护,直接与RPA1/RPA2.2.等DNA修复因子结合.
- *NKX2-1阳性细胞在以托治疗后显示DNA损伤和亡减少,RUNX1被确定为调节NKX2-1活性的关键辅因子.
结论:
- *NKX2-1通过防止DNA损伤,在T-ALL细胞生存中发挥关键作用.
- *RUNX1是T-ALL中NKX2-1的重要辅因子,影响蛋白质复合体组成和细胞存活.
- * 针对NKX2-1/RUNX1合作通路可能为T-ALL提供治疗策略.
相关概念视频
The Intrinsic Apoptotic Pathway
8.3K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.3K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Negative Regulator Molecules
38.2K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.2K
Inhibition of Cdk Activity
5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
Epigenetic Regulation
33.4K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
33.4K
Epigenetic Regulation
3.7K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.7K


